This is part one of a six-part series on drug lifecycle management: Four Strategic ChoicesPrevention Innovation Extraction Adaptation Summary and Conclusion This article is adapted from Song CH, Han J-W. Patent cliff and strategic switch:…
The post Str…
Strategies for Branded Drug Lifecycle Management: Part 1 – Four Strategic Choices Read Post »
Drug patent portfolios often include patents specifically designed to keep rivals from introducing innovative improvements for a period of time The so-called fencing patent, or dominating patent, is a patent…
The post The Evolution of Patent Claims in …
The Evolution of Patent Claims in Drug Lifecycle Management Read Post »
Clinical researchers are beginning to ask why pharmacists are not well-represented on clinical drug trial teams. When most people think of clinical drug trials, they consider patients, doctors, and the…
The post 5 Ways Pharmacists Can Improve Clinical …
Aggressive generic delay practices are troubling because, unlike patent exclusivity, they do not promote any public interest Increasing the costs of drugs has emerged as a core strategy for pharmaceutical…
The post Drugs With No Patents And No Competit…
Drugs With No Patents And No Competition: Here’s Why Read Post »
Many factors influence whether physicians prescribe brand name or generic drugs High prices for prescription drugs are the focus of several bills that are currently working their way through Congress, including bills…
The post Prescribing of Generic Dr…
Prescribing of Generic Drugs Goes Up When Sales Visits Go Down Read Post »
Pharmaceutical companies have devised powerful strategies to forestall their loss of profits post patent expiration Losing patent protection on a drug is the only certainty in the constantly changing world…
The post Using Patent Filings to Model Brande…
Using Patent Filings to Model Branded Pharmaceutical Post-Expiration Strategies Read Post »
In the complex world of intellectual property and pharmaceutical development, understanding the intricacies of patent term extension (PTE) is crucial […]
Companies developing a new drug product, even if it is not an NCE, should explore ways to increase the likelihood of obtaining and maximizing PTE This is a guest post…
The post Patent Term Extension for Drugs not Limited to new Chemical Entities appear…
Patent Term Extension for Drugs not Limited to new Chemical Entities Read Post »
The value of obtaining multiple PTEs on different patents could incentivize innovators to revise their clinical development programs This is a guest post from Nicole Stakleff and Kyle Dolinsky in…
The post How to Obtain Multiple Patent Term Extensions …
How to Obtain Multiple Patent Term Extensions for a Single Product Read Post »
The total cost of developing, manufacturing, testing, and marketing a generic drug in India costs just 20% to 40% of the expenses in the West. A Glimpse of the API…
The post How to find a reputable API supplier appeared first on DrugPatentWatch – Make …
Get new actionable insights and updates from BiotechBlog
